Results 31 to 40 of about 87,373,768 (197)
The impact of stigma on people with opioid use disorder, opioid treatment, and policy.
Illicit drug use disorders are the most stigmatised health conditions worldwide, and stigma acts as a meaningful barrier to treatment entry and treatment provision.
Lubman, Dan I +4 more
core +1 more source
The Lived Experience of Medication for Opioid Use Disorder
Abstract Purpose of the Study Buprenorphine and methadone, when used as maintenance therapy in opioid use disorder (OUD), can significantly reduce the risk of death after an opioid overdose. Despite the many benefits, medication for OUD (MOUD) remains controversial and underutilized.
Aimee Techau +3 more
openaire +2 more sources
Educating the community about the opioid epidemic and medications for opioid use disorder
AbstractBackground and ObjectivesDespite overwhelming evidence of benefit, medications for opioid use disorder (MOUD) remain stigmatizing and more efforts are needed to educate health care professionals and the general public.MethodsWe developed and evaluated an educational program for graduate students studying health sciences, teaching them to ...
Jill M. Williams +5 more
openaire +2 more sources
This is a protocol for a scoping review that seeks to determine the scope of available evidence comparing access to medications for opioid use disorder in urban and rural ...
Erin L. Winstanley +5 more
core +1 more source
Prescribers’ satisfaction with delivering medications for opioid use disorder [PDF]
Abstract Background Expanding access to medications for opioid use disorder (MOUD), such as buprenorphine and extended release (XR) naltrexone, is critical to addressing the US opioid epidemic, but little is known about prescriber satisfaction with delivering these two types of MOUD.
Knudsen, Hannah K +8 more
openaire +5 more sources
Effect of police action on low-barrier substance use disorder service utilization
Background Police action can increase risky substance use patterns by people who use drugs (PWUD), but it is not known how increased police presence affects utilization of low-barrier substance use disorder bridge clinics.
Karrin Weisenthal +5 more
doaj +1 more source
A scoping review aimed at summarizing current literature which describes policies related to treatment of opioid use disorder with medications within professional recovery programs for physicians, pharmacists, and ...
Lucas Hill, Kelley White
core +1 more source
Trends in Access to Medications for Opioid Use Disorder.
ImportanceMedicaid, the largest payer for medications for opioid use disorder (MOUD), disenrolled more than 19.1 million individuals by March 2024 after the continuous coverage requirement ended in April 2023—a process termed Medicaid unwinding—but the impact on buprenorphine receipt remains unknown.ObjectiveTo assess the association between Medicaid ...
Gupta S +5 more
europepmc +3 more sources
We will identify the landscape of studies regarding problem-solving court staff attitudes, policies, and practices related to medications for opioid use ...
Sarah Akil +3 more
core +1 more source
Availability of Medications for Opioid Use Disorder in Opioid Treatment Programs.
ImportanceAs the primary facilities authorized to dispense methadone, opioid treatment programs (OTPs) are a critical access point for medications for opioid use disorder (MOUD). However, research is limited on the extent to which OTPs offer a broad range of MOUD and on the characteristics of programs that provide more comprehensive medication ...
Lindenfeld Z +5 more
europepmc +3 more sources

